Orphanet Journal of Rare Diseases | Neurocognitive Features and Academic Impact in Children with GA-1

Recommend:

This study, based on Spain's national GA-1 registry, systematically analyzed the relationship between neurocognitive function and learning disabilities in 42 pediatric patients, revealing patterns of cognitive deficits across age groups and emphasizing the importance of personalized educational interventions.

 

Literature Overview

This article, titled 'Neurocognitive characterization and academic impact in pediatric patients belonging to the national registry of GA-1,' published in the Orphanet Journal of Rare Diseases, reviews and summarizes the impact of glutaric aciduria type I (GA-1) on children's neurocognitive development and academic abilities. The study employed various psychometric tools to assess cognition, attention, executive function, and motor skills, and used statistical analysis to identify key variables affecting academic performance. It highlights that despite early dietary interventions, significant learning difficulties persist, with approximately 60% of patients requiring special educational support. The study further explores the relationship between biochemical subtypes and cognitive outcomes, providing empirical evidence for clinical management and educational interventions.

Background Knowledge

GA-1 is a rare metabolic disorder caused by mutations in the GCDH gene, characterized by a deficiency of glutaryl-CoA dehydrogenase (GDH), leading to the accumulation of glutaric acid and 3-hydroxyglutaric acid—metabolic byproducts of lysine, hydroxylysine, and tryptophan—in the body. These substances are neurotoxic to the central nervous system, particularly damaging to neurological development in infants. Although recent advances in newborn screening and low-lysine diets have improved clinical outcomes, neurocognitive deficits remain one of the primary challenges. Previous studies suggest a significant association between different biochemical subtypes (HE and LE) and cognitive performance, indicating the role of biochemical markers in disease phenotypes and prognosis. This study leverages the national registry and multi-center data with advanced statistical tools to conduct an in-depth analysis of neurocognitive deficits across age groups and their specific impact on academic performance, offering scientific support for personalized intervention strategies.

 

Used to predict the potential phenotypes resulting from gene knockouts, providing preliminary references for experimental design.

Learn More

 

Research Methods and Experimental Design

This study is a prospective, observational, multi-center investigation that included 42 GA-1 patients (25 boys and 17 girls) aged 0 to 16 years. All participants were recruited from the national GA-1 registry managed by the 12 de Octubre University Hospital in Spain. Standardized psychometric tools (e.g., Bayley-III, KABC, WISC, WAIS-IV) were used to assess cognitive development, executive function, attention, motor skills, and processing speed across different age groups. Data analysis was performed using analysis of variance (ANOVA) and random forest modeling to identify key variables influencing academic performance. To address multicollinearity, the researchers employed VIF detection and applied principal component analysis (PCA) for dimensionality reduction.

Key Findings and Perspectives

• GA-1 patients exhibit significant heterogeneity in neurocognitive function. Children under 4 years old show normal cognitive development but exhibit deficits in gross motor skills.
• Patients over 4 years old demonstrate average IQ scores on intelligence tests, but show moderate to severe impairments in executive function, attention, and visual perception.
• Approximately 60% of school-aged patients require special educational support, highlighting the substantial challenges GA-1 patients face in mainstream education.
• Principal component analysis (PCA) identified IQ, fluid intelligence, and attention as the most critical variables influencing academic performance.
• Regression analysis reveals that higher IQ and fluid intelligence are significantly associated with reduced need for educational support, while attention capacity is another key factor.
• Despite early treatment reducing neurological damage, neurocognitive impairments remain widespread, necessitating ongoing monitoring and personalized interventions.

Significance and Future Directions

The study underscores the neurocognitive challenges faced by GA-1 patients in academic settings, offering empirical support for early diagnosis and personalized educational interventions. Future research should further explore the relationship between diagnosis timing, biochemical subtypes, and both neurocognitive and academic outcomes, as well as conduct longitudinal studies to evaluate intervention efficacy. Additionally, integrating neuroimaging and genotypic data may help elucidate the molecular mechanisms behind different phenotypes and their cognitive impacts.

 

A practical tool for rapidly mapping DNA or RNA sequences to the genome, supporting sequence alignment and annotation.

Learn More

 

Conclusion

GA-1 is a rare metabolic disorder affecting neurological development. Although patients receive early treatment, significant individual variability in neurocognitive function remains. Children under 4 primarily exhibit gross motor deficits, while those over 4 demonstrate moderate to severe impairments in executive function, attention, and visual perception. The study validates through PCA and regression models that IQ, fluid intelligence, and attention are the primary factors affecting academic performance, highlighting the need for clinical assessment and intervention of these functions. Future research must further clarify the relationship between biochemical subtypes and cognitive impairments, and explore more effective educational support strategies to improve long-term outcomes. This study provides a new perspective for the personalized management of GA-1 and emphasizes the importance of early identification and intervention in preventing neurocognitive sequelae.

 

Zamora-Crespo Berta, Moreno-Ramos Zaida, Martínez de Aragón Ana, Martín-Hernández Elena, and Quijada-Fraile Pilar. Neurocognitive characterization and academic impact in pediatric patients belonging to the national registry of GA-1. Orphanet Journal of Rare Diseases.